LifeSci Acquisition II (LSAQ): Price and Financial Metrics

LifeSci Acquisition II (LSAQ): $9.01

0.24 (-2.59%)

POWR Rating

Component Grades








Add LSAQ to Watchlist
Sign Up

Industry: Miscellaneous




in industry

LSAQ Price/Volume Stats

Current price $9.01 52-week high $12.68
Prev. close $9.25 52-week low $8.42
Day low $8.42 Volume 41,600
Day high $9.02 Avg. volume 53,514
50-day MA $9.92 Dividend yield N/A
200-day MA $10.32 Market Cap 90.20M

LSAQ Stock Price Chart Interactive Chart >

LifeSci Acquisition II (LSAQ) Company Bio

LifeSci Acquisition II Corp. operates as a blank check company. It is formed for the purpose of effecting a merger, capital stock exchange, asset acquisition, stock purchase, reorganization or similar business combination with one or more businesses for its initial business. The company was founded on December 18, 2019 and is headquartered in New York.

LSAQ Latest News Stream

Event/Time News Detail
Loading, please wait...

LSAQ Latest Social Stream

Loading social stream, please wait...

View Full LSAQ Social Stream

Latest LSAQ News From Around the Web

Below are the latest news stories about Lifesci Acquisition II Corp that investors may wish to consider to help them evaluate LSAQ as an investment opportunity.

SHAREHOLDER ALERT: Rigrodsky Law, P.A. Announces Investigation of LifeSci Acquisition II Corp. Merger

WILMINGTON, Del., May 12, 2021 (GLOBE NEWSWIRE) -- Rigrodsky Law, P.A. announces that it is investigating LifeSci Acquisition II Corp. (“LifeSci”) (NASDAQ GS: LSAQ) regarding possible breaches of fiduciary duties and other violations of law related to LifeSci’s agreement to merge with Science 37, Inc. To learn more about this investigation and your rights, visit: You may also contact Seth D. Rigrodsky or Gina M. Serra cost and obligation free at (888) 969-4242 or [email protected]. Rigrodsky Law, P.A., with offices in Delaware and New York, has recovered hundreds of millions of dollars on behalf of investors and achieved substantial corporate governance reforms in securities fraud and corporate class actions nationwide. Attorne...

Yahoo | May 12, 2021

SHAREHOLDER ALERT: Monteverde & Associates PC Announces an Investigation of LifeSci Acquisition II Corp. - LSAQ

Juan Monteverde, founder and managing partner at Monteverde & Associates PC, a national securities firm rated Top 50 in the 2018-2020 ISS Securities Class Action Services Report and headquartered at the Empire State Building in New York City, is investigating LifeSci Acquisition II Corp. ("LSAQ" or the "Company") (LSAQ) relating to its proposed merger with Science 37, Inc. Under the terms of the agreement, LSAQ will acquire Science 37 through a reverse merger, with Science 37 emerging as a publicly traded company.

Yahoo | May 12, 2021

Moore Kuehn Encourages MNR, LOKB, LSAQ and MFNC Investors to Contact Law Firm

NEW YORK, May 11, 2021 (GLOBE NEWSWIRE) -- Moore Kuehn, PLLC, a law firm focusing in securities litigation located on Wall Street in downtown New York City, is investigating potential claims concerning whether the following proposed mergers are fair to shareholders. Moore Kuehn may seek increased consideration, additional disclosures, or other relief on behalf of the shareholders of these companies: Monmouth Real Estate Investment Corporation (NYSE: MNR) Monmouth has agreed to merge with Equity Commonwealth. Under the proposed transaction, Monmouth shareholders will receive $19.58 in cash per share. Live Oak Acquisition Corp. II (NYSE: LOKB) Live Oak II has agreed to merge with Navitas Semiconductor. Under the proposed transaction, Live Oak II shareholders will only own 18.1% of the com...

Yahoo | May 11, 2021

LifeSci Acquisition II Corp. Announces Pricing of $75 Million Initial Public Offering

NEW YORK, Nov. 20, 2020 (GLOBE NEWSWIRE) -- LifeSci Acquisition II Corp. (NASDAQ: LSAQ), a blank check company targeting the biopharma sector, announced today that it priced its initial public offering of 7,500,000 shares at $10.00 per share. The shares will begin trading today on the NASDAQ Capital Market (“NASDAQ”) under the symbol “LSAQ.” LifeSci Capital LLC acted as lead book-running manager and Ladenburg Thalmann & Co. Inc. acted as joint book-running manager for the offering (the “Underwriters”). The underwriters have been granted a 45-day option to purchase up to an additional 1,125,000 shares offered by the Company to cover over-allotments, if any.The offering is expected to close on or about November 24, 2020, subject to customary closing conditions.A registration statement re...

Yahoo | November 20, 2020

Read More 'LSAQ' Stories Here

LSAQ Price Returns

1-mo N/A
3-mo N/A
6-mo N/A
1-year N/A
3-year -10.88%
5-year N/A
2023 N/A
2022 N/A
2021 0.00%
2020 N/A
2019 N/A

Get Free Updates

Join thousands of investors who get the latest news, insights and top rated picks from!